Morsy, K. H., Zaghloul, A., & Mahmoud, M. (2016). Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?. Turkish Journal of Gastroenterology, 27(1), 55–61. https://doi.org/10.5152/tjg.2015.150280